Integra LifeSciences Securities Litigation

IL

Integra LifeSciences · Integra LifeSciences shares and disclosures concerning its medical-device manufacturing operations

Investors allege that Integra LifeSciences and certain executives made misleading statements concerning manufacturing, quality, and regulatory problems. The court granted defendants’ motion to dismiss the original consolidated complaint with leave to amend; plaintiffs filed an amended complaint, defendants moved to dismiss it, and the matter remains ongoing with briefing completed and oral argument not yet scheduled.